Chimeric antigen receptor T cell therapy reduces vaccine immunity, with many patients lacking seroprotection despite stable antibody levels.

In patients with severe obesity, the recombinant influenza vaccine yields stronger short-term antibody responses than the egg-based standard-dose vaccine, with no safety concerns noted.

Evaxion Biotech A/S has announced promising new data on its personalized cancer vaccine, EVX-01, highlighting that 80% of the vaccine's targets elicited a tumor-specific immune response, significantly ...

The immune system works to maintain homeostasis throughout the body. Various cell types and immune mechanisms work in concert to fight disease. Specifically, two waves of immunity orchestrate a robust ...

A team has identified a previously unknown phase of the immune response. The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ...

Harmonizing immunophenotyping assay designs facilitates integrating findings across trials, enabling biomarker identification and validation, revealing cohort-specific features and drug mechanisms as ...

A small patch, no larger than a bandage, may soon change how doctors understand the immune system. Instead of relying on ...

Preclinical models demonstrate potential to restore thymic function lost with aging reducing susceptibility to cancer, autoimmune diseases, infections, and reduced vaccine efficacy ...

Medically reviewed by Daniel More, MD Key Takeaways Echinacea may lower your risk of catching a cold, while zinc is more ...

Christopher Locher, PhD, CEO, Versatope Therapeutics, Inc., tells his us about his version of a universal flu vaccine while ...